Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial.
Macfadyen
Carolyn
C
Internatinal Health Research Group, Liverpool School of Tropical Medicine, Liverpool, UK.
Gamble
Carrol
C
Garner
Paul
P
Macharia
Isaac
I
Mackenzie
Ian
I
Mugwe
Peter
P
Oburra
Herbert
H
Otwombe
Kennedy
K
Taylor
Stephen
S
Williamson
Paula
P
D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001309:Auditory Threshold / Q000502:physiology; D001888:Boric Acids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D003906:Developing Countries; D006311:Hearing Disorders / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods; D010035:Otitis Media, Suppurative / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology; D010146:Pain / Q000175:diagnosis / Q000209:etiology; D012720:Severity of Illness Index; D014432:Tympanic Membrane / Q000187:drug effects
D000890:Anti-Infective Agents; D001888:Boric Acids; D002939:Ciprofloxacin; C032688:boric acid